U.S. Securities and Exchange Commission
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
FEBRUARY 21, 2012 (FEBRUARY 15, 2012)
Date of Report (Date of earliest event Reported)
MESA LABORATORIES, INC.
(Exact Name of Small Business Issuer as Specified in its Charter)
Commission File Number: 0-11740
|
COLORADO |
|
84-0872291 |
|
12100 WEST SIXTH AVENUE, LAKEWOOD, COLORADO |
|
80228 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
Issuer’s telephone number, including area code: (303) 987-8000
Not Applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01 Regulation FD Disclosure
On February 15, 2012, the Company’s CEO, John J. Sullivan Ph.D., made a presentation at the RedChip Small-Cap Equities Virtual Conference. In conjunction with that presentation, the Company presented slides highlighting the company’s performance, products, markets and goals. A copy of the slides that were presented is furnished as Exhibit 99.1 to this Current Report on Form 8-K
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Mesa Laboratories, Inc. Investor Presentation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MESA LABORATORIES, INC. |
| |
|
(Issuer) |
| |
|
|
| |
|
|
| |
|
DATED: February 21, 2012 |
BY: |
/s/ John J. Sullivan, Ph.D. |
|
|
|
John J. Sullivan, Ph.D. |
|
|
|
Chief Executive Officer, |
INDEX TO EXHIBITS
|
Exhibit No. |
|
Description |
|
Method of Filing |
|
|
|
|
|
|
|
99.1 |
|
Mesa Laboratories, Inc. |
|
Filed herewith |